ARCHIVES

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

This article is from The Cancer Letter archive.

Vol. 02 No. 48 | November 26, 1976

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 2 Issue 2, Spring 1988

April 13, 1988

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005

Concept Approved For New Quality Assurance Center

May 14, 1982